摘要
目的探讨大肠癌合并肠梗阻术后ICU脓毒症患者应用血必净的临床效果。方法我院2012年1月~2014年12月间68例大肠癌合并肠梗阻术后ICU脓毒症患者,随机分为对照组（34例）和观察组（34例）,均给予常规治疗,观察组加用血必净注射液,比较两组疗效及炎症相关指标。结果观察组治疗总有效率94.12%（32/34）明显高于对照组73.53%（25/32）,治疗后患者血清IL、WBC、GR、TNF等指标水平均优于对照组,差异具有统计学意义（P〈0.05）。结论大肠癌合并肠梗阻术后ICU脓毒症患者应用血必净可有效减轻患者机体炎症反应,效果较好。
Objective To investigate the clinical of Xuebijing for ICU sepsis with colorectal carcinoma with intestinal obstruction. Methods 68 csaes of ICU sepsis with colorectal carcinoma with intestinal obstruction from January 2012 to December 2014, were randomly divided into control group（34 cases） and observation group（34 cases）, were given conventional treatment, the observation group and Xuebijing injection, compare two groups of curative effect and inflammation related indicators. Results In the observation group total effective rate 94.12%（32/34） was significantly higher than that in control group 73.53%（25/32）, after treatment the serum levels of IL, WBC, GR, TNF and other indexes were significantly better than the group level（P〈0.05）. Conclusion Xuebijing injection in the treatment of postoperative colorectal cancer complicated with intestinal obstruction after sepsis in ICU good effect, worthy of clinical application.
出处
《中国继续医学教育》
2015年第5期250-251,共2页
China Continuing Medical Education
关键词
血必净
大肠癌合并肠梗阻
ICU
脓毒症
Xuebijing
Colorectal carcinoma with intestinal obstruction
ICU
Sepsis
